Lillian Y. Lai, MD,MS

University of Michigan

I am in my second and last year of the NIH T32 funded urologic oncology research fellowship at the University of Michigan. I am excited to share with you three posters: 1) HIGH LEVELS OF HIDDEN SEGREGATION EXIST FOR BLACK AND WHITE PATIENTS UNDERGOING CANCER SURGERY WITHIN THE SAME HOSPITAL, 2) RISK OF METABOLIC AND CARDIOVASCULAR ADVERSE EVENTS WITH ABIRATERONE OR ENZALUTAMIDE AMONG MEN WITH ADVANCED PROSTATE CANCER, and 3) PROLIFERATION OF PHYSICIAN DISPENSING AMONG LARGE SINGLE-SPECIALTY MEDICAL ONCOLOGY AND UROLOGY PRACTICES.

Disclosure information not submitted.

Presentation(s):

• MP28-12: Proliferation of physician dispensing among large single-specialty medical oncology and urology practices

  Saturday, May 14, 2022
  1:00 PM – 2:15 PM

• MP31-12: High Levels of Hidden Segregation Exist for Black and White Patients Undergoing Cancer Surgery within the Same Hospital

  Saturday, May 14, 2022
  2:45 PM – 4:00 PM

• MP48-19: Risk of metabolic and cardiovascular adverse events with abiraterone or enzalutamide among men with advanced prostate cancer

  Sunday, May 15, 2022
  2:45 PM – 4:00 PM